Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Market Information and Holders of Record
On March 4, 2021, shares of our common stock were approved for trading on the OTCQB Venture Market under the symbol “CMPX”.
As of February 25, 2021, there were approximately 220 stockholders of record of our common stock. The actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees.
Dividends
We currently intend to retain future earnings, if any, to maintain and expand our operations. We have never declared or paid cash dividends on our common stock and we do not intend to pay any cash dividends on our common stock for the foreseeable future. In addition, our 2018 Credit Facility contains, and any future debt financing arrangement we enter into may contain, terms prohibiting or limiting the amount of dividends that may be declared or paid on our common stock. Any future determination related to our dividend policy will be made at the discretion of our board of directors in light of conditions then-existing, including factors such as our results of operations, financial condition and requirements, business conditions and covenants under any applicable contractual arrangements.
Item 6. Selected Financial Data.
The following selected financial data should be read together with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and related notes included elsewhere in this Form 10-K. The selected statements of operations for the years ended December 31, 2020 and 2019 and the selected balance sheet data as of December 31, 2020 and 2019 have been derived from our audited financial statements that are included elsewhere in this Form 10-K. Historical results are not necessarily indicative of the results to be expected in the future.
Year Ended
December 31,
2020
2019
(000's)
Statement of Operations Data:
Operating expenses:
Research and development expense
$
14,904
$
22,449
General and administrative expense
12,908
11,603
Total operating expenses
27,812
34,052
Operating loss
(27,812
)
(34,052
)
Other income (expense):
Interest expense
(908
)
(1,228
)
Other income (expense), net
(780
)
536
Total other expense
(1,688
)
(692
)
Net loss
$
(29,500
)
$
(34,744
)
Basic and diluted loss per common share
$
(0.96
)
$
(5.19
)
Basic and diluted weighted average common shares outstanding
30,776
6,691
100
2020
2019
(000's)
Balance Sheet Data
Cash and cash equivalents
$
47,076
$
25,303
Working capital
40,103
16,417
Total assets
51,911
30,381
Debt (current and noncurrent portions)
9,334
14,869
Total stockholders’ equity (deficit)
39,945
(118,603
)
101
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.